Axsome Therapeutics Inc (AXSM)
99.95
-0.54
(-0.54%)
USD |
NASDAQ |
Dec 04, 14:11
Axsome Therapeutics Price to Book Value: 52.14 for Dec. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 52.42 |
| December 02, 2024 | 51.69 |
| November 29, 2024 | 51.24 |
| November 27, 2024 | 51.98 |
| November 26, 2024 | 50.62 |
| November 25, 2024 | 50.86 |
| November 22, 2024 | 51.48 |
| November 21, 2024 | 51.22 |
| November 20, 2024 | 49.35 |
| November 19, 2024 | 49.80 |
| November 18, 2024 | 48.23 |
| November 15, 2024 | 48.60 |
| November 14, 2024 | 50.80 |
| November 13, 2024 | 51.04 |
| November 12, 2024 | 51.90 |
| November 11, 2024 | 47.46 |
| November 08, 2024 | 46.99 |
| November 07, 2024 | 47.32 |
| November 06, 2024 | 47.46 |
| November 05, 2024 | 46.55 |
| November 04, 2024 | 45.49 |
| November 01, 2024 | 46.32 |
| October 31, 2024 | 46.42 |
| October 30, 2024 | 46.64 |
| October 29, 2024 | 47.11 |
| Date | Value |
|---|---|
| October 28, 2024 | 46.98 |
| October 25, 2024 | 46.86 |
| October 24, 2024 | 46.32 |
| October 23, 2024 | 48.13 |
| October 22, 2024 | 48.17 |
| October 21, 2024 | 47.71 |
| October 18, 2024 | 48.67 |
| October 17, 2024 | 48.67 |
| October 16, 2024 | 46.91 |
| October 15, 2024 | 45.06 |
| October 14, 2024 | 44.54 |
| October 11, 2024 | 45.65 |
| October 10, 2024 | 43.32 |
| October 09, 2024 | 43.56 |
| October 08, 2024 | 44.22 |
| October 07, 2024 | 43.88 |
| October 04, 2024 | 45.15 |
| October 03, 2024 | 47.54 |
| October 02, 2024 | 48.61 |
| October 01, 2024 | 47.19 |
| September 30, 2024 | 46.86 |
| September 27, 2024 | 41.83 |
| September 26, 2024 | 41.83 |
| September 25, 2024 | 41.96 |
| September 24, 2024 | 42.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
8.547
Minimum
Mar 18 2020
573.18
Maximum
Dec 26 2019
39.83
Average
23.68
Median
Jun 10 2024
Price to Book Value Benchmarks
| Repligen Corp | 4.111 |
| Pfizer Inc | 1.549 |
| NovaBay Pharmaceuticals Inc | 2.750 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
Price to Book Value Related Metrics
| PS Ratio | 14.06 |
| PEG Ratio | -0.3467 |
| Price | 99.95 |
| Earnings Yield | -6.53% |
| Market Cap | 4.844B |
| PEGY Ratio | -0.3467 |